Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities

Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (4a-c and 5a-c) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The (EZ)-7-cyano-6-((4-hydroxybenzylidene)amino)-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-car...

Full description

Saved in:
Bibliographic Details
Main Authors: Gouda Ahmed M., Abdelazeem Ahmed H., Abdalla Ashraf N., Ahmed Muhammad
Format: Article
Language:English
Published: Sciendo 2018-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2018-0026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574147422584832
author Gouda Ahmed M.
Abdelazeem Ahmed H.
Abdalla Ashraf N.
Ahmed Muhammad
author_facet Gouda Ahmed M.
Abdelazeem Ahmed H.
Abdalla Ashraf N.
Ahmed Muhammad
author_sort Gouda Ahmed M.
collection DOAJ
description Towards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (4a-c and 5a-c) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The (EZ)-7-cyano-6-((4-hydroxybenzylidene)amino)-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4b) and (EZ)-6-((4-chlorobenzylidene)-amino)-7-cyano-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5b) bearing the electron donating methyl group showed the highest anti-inflammatory activity while (EZ)-6-((4-chlorobenzylidene)amino)-7-cyano-N-phenyl-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5a) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds 4b and 5b displayed high anticancer activity with IC50 in the range of 0.30–0.92 μmol L−1 against the three cell lines, while compound (EZ)-N-(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4c) was the most active against MCF-7 cells (IC50 = 0.08 μmol L−1). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound 5b, the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.
format Article
id doaj-art-1c40235d4cb3418397e9399d19c5e59f
institution Kabale University
issn 1846-9558
language English
publishDate 2018-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-1c40235d4cb3418397e9399d19c5e59f2025-02-02T00:32:27ZengSciendoActa Pharmaceutica1846-95582018-09-0168325127310.2478/acph-2018-0026acph-2018-0026Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activitiesGouda Ahmed M.0Abdelazeem Ahmed H.1Abdalla Ashraf N.2Ahmed Muhammad3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University, Makkah21955, Saudi ArabiaDepartment of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef62514, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah21955, Saudi ArabiaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah21955, Saudi ArabiaTowards optimization of the pyrrolizine-5-carboxamide scaffold, a novel series of six derivatives (4a-c and 5a-c) was prepared and evaluated for their anti-inflammatory, analgesic and anticancer activities. The (EZ)-7-cyano-6-((4-hydroxybenzylidene)amino)-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4b) and (EZ)-6-((4-chlorobenzylidene)-amino)-7-cyano-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5b) bearing the electron donating methyl group showed the highest anti-inflammatory activity while (EZ)-6-((4-chlorobenzylidene)amino)-7-cyano-N-phenyl-2,3-dihydro-1H-pyrrolizine-5-carboxamide (5a) was the most active analgesic agent. Cytotoxicity of the new compounds was evaluated against the MCF-7, A2780 and HT29 cancer cell lines using the MTT assay. Compounds 4b and 5b displayed high anticancer activity with IC50 in the range of 0.30–0.92 μmol L−1 against the three cell lines, while compound (EZ)-N-(4-chlorophenyl)-7-cyano-6-((4-hydroxybenzylidene)-amino)-2,3-dihydro-1H-pyrrolizine-5-carboxamide (4c) was the most active against MCF-7 cells (IC50 = 0.08 μmol L−1). Both the anti-inflammatory and anticancer activities of the new compounds were dependent on the type of substituent on the phenyl rings. Substituents with opposite electronic effects on the two phenyl rings are preferable for high cytotoxicity against the MCF-7 and A2780 cells. COX inhibition was suggested as the molecular mechanism of the anti-inflammatory activity of the new compounds while no clear relationship could be observed between COX inhibition and anticancer activity. Compound 5b, the most active against the three cell lines, induced dose-dependent early apoptosis with 0.1–0.2 % necrosis in MCF-7 cells. New compounds showed promising drug-likeness scores while the docking study revealed high binding affinity to COX-2. Taken together, this study highlighted the significant impact of the substituents on the anti-inflammatory and anticancer activity of pyrrolizine-5-carboxamides, which could help in further optimization to discover good leads for the treatment of cancer and inflammation.https://doi.org/10.2478/acph-2018-0026pyrrolizine-5-carboxamideanticanceranti-inflammatorycoxsapoptosissubstituent electronic effect
spellingShingle Gouda Ahmed M.
Abdelazeem Ahmed H.
Abdalla Ashraf N.
Ahmed Muhammad
Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
Acta Pharmaceutica
pyrrolizine-5-carboxamide
anticancer
anti-inflammatory
coxs
apoptosis
substituent electronic effect
title Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
title_full Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
title_fullStr Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
title_full_unstemmed Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
title_short Pyrrolizine-5-carboxamides: Exploring the impact of various substituents on anti-inflammatory and anticancer activities
title_sort pyrrolizine 5 carboxamides exploring the impact of various substituents on anti inflammatory and anticancer activities
topic pyrrolizine-5-carboxamide
anticancer
anti-inflammatory
coxs
apoptosis
substituent electronic effect
url https://doi.org/10.2478/acph-2018-0026
work_keys_str_mv AT goudaahmedm pyrrolizine5carboxamidesexploringtheimpactofvarioussubstituentsonantiinflammatoryandanticanceractivities
AT abdelazeemahmedh pyrrolizine5carboxamidesexploringtheimpactofvarioussubstituentsonantiinflammatoryandanticanceractivities
AT abdallaashrafn pyrrolizine5carboxamidesexploringtheimpactofvarioussubstituentsonantiinflammatoryandanticanceractivities
AT ahmedmuhammad pyrrolizine5carboxamidesexploringtheimpactofvarioussubstituentsonantiinflammatoryandanticanceractivities